Hemoporfin API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Hemoporfin API 14459-29-1?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Hemoporfin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Hemoporfin
- Synonyms:
- Haematoporphyrin , Hematoporphyrin , Hematoporphyrin ix , Photodyn
- Cas Number:
- 14459-29-1
- DrugBank number:
- DB16183
- Unique Ingredient Identifier:
- HBT6M5H379
General Description:
Hemoporfin, identified by CAS number 14459-29-1, is a notable compound with significant therapeutic applications. Hemoporfin is under investigation in clinical trial NCT03125057 (A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain).
Categories:
Hemoporfin is categorized under the following therapeutic classes: Biological Factors, Dermatologicals, Heterocyclic Compounds, Fused-Ring, Photosensitizing Agents, Pigments, Biological, Porphyrins, Radiation-Sensitizing Agents. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Hemoporfin is a type of Dermatological Agents
Dermatological agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the formulation of various skincare and dermatology products. These APIs are specifically designed to target and treat skin conditions, offering effective solutions for a wide range of dermatological concerns.
Dermatological agents encompass a diverse array of compounds, including corticosteroids, antifungal agents, antibacterials, retinoids, and immunomodulators. Each API within this category possesses unique properties and mechanisms of action, enabling them to address specific skin-related issues.
Corticosteroids, for instance, are potent anti-inflammatory agents commonly used in the treatment of skin conditions like eczema, psoriasis, and dermatitis. Antifungal agents, on the other hand, combat fungal infections such as athlete's foot or ringworm. Antibacterials are effective against bacterial infections, while retinoids promote skin cell turnover and treat acne and photoaging. Immunomodulators regulate the immune response, providing relief from conditions like atopic dermatitis.
The development and application of dermatological APIs involve rigorous research, clinical trials, and regulatory compliance. These APIs are typically integrated into topical creams, ointments, gels, and lotions, ensuring targeted delivery to the affected areas of the skin.
Dermatological agents play a crucial role in the management and treatment of various skin disorders. By harnessing the therapeutic properties of these APIs, pharmaceutical companies can develop innovative skincare products that cater to the diverse needs of individuals seeking effective dermatological solutions.
